CharlesRCaginDO
Cardiology • La Crosse, WICardiac Electrophysiology, Interventional Cardiology
Cardiologist and Assistant Professor
Dr. Cagin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 West Ave S
La Crosse, WI 54601Phone+1 608-392-9862Fax+1 608-392-7881
Summary
- Dr. Charles Cagin is a cardiologist in La Crosse, WI and is affiliated with multiple hospitals in the area, including Mayo Clinic Hospital - Rochester and Mayo Clinic Health System - Franciscan Healthcare in Sparta. He received his medical degree from Des Moines University College of Osteopathic Medicine and has been in practice 43 years. He specializes in interventional cardiology and is experienced in valvular heart disease, cardiac catheterization, cardiac critical care, and icd / pacemaker insertion.
Education & Training
University of ToledoFellowship, Cardiovascular Disease, 1977 - 1979
Mount Sinai Hospital Medical Center of ChicagoResidency, Internal Medicine, 1975 - 1977
University at BuffaloInternship, Internal Medicine, 1974 - 1975
Des Moines University College of Osteopathic MedicineClass of 1974
Certifications & Licensure
IA State License 1979 - 2025
MN State License 2003 - 2025
WI State License 2003 - 2025
IL State License 1976 - 2002
OH State License 1977 - 1979- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- Tailored Antiplatelet Therapy Following PCI Start of enrollment: 2013 May 01
Publications & Presentations
PubMed
- 239 citationsEffect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-...Naveen L. Pereira, Michael E. Farkouh, Derek So, Ryan J. Lennon, Nancy L. Geller
JAMA. 2020-08-25 - 19 citationsRapid Exclusion of Acute Myocardial Injury and Infarction With a Single High-Sensitivity Cardiac Troponin T in the Emergency Department: A Multicenter United States Ev...Yader Sandoval, Bradley R Lewis, Ramila A Mehta, Olatunde Ola, Jonathan D Knott
Circulation. 2022-06-07 - 32 citationsBullets, Lead Poisoning, and ThyrotoxicosisCharles R. Cagin, Mila Diloy-Puray, Maxwell P. Westerman
Annals of Internal Medicine. 1978-10-01
Journal Articles
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionNaveen L Pereira, Verghese Mathew, Charles Cagin, Amir Lerman, Charanjit Rihal, JAMA
Authored Content
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
- Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary InterventionAugust 2020
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
